Castle Biosciences

IPO

Innovative Molecular Prognostic and Diagnostic Tests

Public · FRIENDSWOOD, United States · $50.5M raised

Headquarters
FRIENDSWOOD, Texas
Employees
501–1000
Business Model
B2B
Total Funding
$50.5M
Last Round
$12.0M Series FApr 2019
Rounds
6
Type
Public

About

Castle Biosciences is a leading diagnostics company delivering advanced molecular diagnostics and prognostic tests, including genomic profiling for melanoma and other skin cancers, to guide patient care and improve outcomes.

Summary

Castle Biosciences is a Healthcare company based in FRIENDSWOOD, United States. It has raised $50.5M in total across 6 rounds, most recently a $12.0M Series F round in Apr 2019. Investors include American Cancer Society BrightEdge Fund, Industry Ventures and HealthQuest Capital.

Tech & App Stack

4 technologies & apps tracked

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

IPOJul 2019
$64.0M

Sign up to see all 7 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies